| __timestamp | Alkermes plc | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 170914000 | 51256000 |
| Thursday, January 1, 2015 | 144942000 | 77347000 |
| Friday, January 1, 2016 | 226424000 | 104189000 |
| Sunday, January 1, 2017 | 335737000 | 90795000 |
| Monday, January 1, 2018 | 492448000 | 106985000 |
| Tuesday, January 1, 2019 | 477729000 | 131923000 |
| Wednesday, January 1, 2020 | 465852000 | 143340000 |
| Friday, January 1, 2021 | 569838000 | 199739000 |
| Saturday, January 1, 2022 | 893687000 | 248860000 |
| Sunday, January 1, 2023 | 1410368000 | 351121000 |
| Monday, January 1, 2024 | 1312301000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding financial health is crucial. Over the past decade, Alkermes plc and Amphastar Pharmaceuticals, Inc. have shown distinct trajectories in gross profit. From 2014 to 2023, Alkermes plc experienced a remarkable growth of over 700%, peaking in 2023 with a gross profit that was nearly four times that of Amphastar. In contrast, Amphastar's growth, while steady, was more modest, increasing by approximately 580% over the same period. This divergence highlights Alkermes' aggressive expansion and strategic positioning in the market. The data underscores the importance of strategic investments and market positioning in driving financial success. As the pharmaceutical industry continues to evolve, these insights provide a valuable lens through which to assess future growth potential.
Who Generates Higher Gross Profit? Novo Nordisk A/S or Alkermes plc
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Pfizer Inc. and Alkermes plc Trends
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S and Alkermes plc: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Alkermes plc vs Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Alkermes plc and Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alkermes plc vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? MorphoSys AG or Amphastar Pharmaceuticals, Inc.